OCT 9, 2026 · REVIEW
A systematic review of oral cancer drug therapies after metabolic bariatric surgery: what oncologists need to know about altered pharmacokinetics
Expert Opinion on Drug Metabolism & Toxicology
INTRODUCTION: Metabolic bariatric surgery (MBS) may substantially alter the pharmacokinetics of orally administered drugs, yet its impact on oral cancer drug therapies remains poor